Loading clinical trials...
Loading clinical trials...
A Randomized, Open-label, Single-Dose, 2-Treatment, 2-Way, 2-Period Crossover Study to Compare the Safety and the Pharmacokinetic Characteristics of MKT-N2 (Montelukast) and Singulair® (Montelukast Sodium) Tablet 10mg in Healthy Male Korean Subjects
Conditions
Interventions
Montelukast
Montelukast sodium
Locations
1
South Korea
Inha University Hospital
Incheon, Junggu, South Korea
Start Date
November 1, 2013
Primary Completion Date
January 1, 2014
Completion Date
March 1, 2014
Last Updated
April 29, 2015
Lead Sponsor
PharmaKing
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions